The convergence of advancements in AI and biology, coupled with a rise in high-risk research, escalating global tensions, and a weakened U.S. public health system, collectively increases the likelihood of a devastating human-made pathogen emerging. This pivotal moment for medical innovation also magnifies the risk of catastrophic lab accidents or intentional misuse. Experts note that the same cutting-edge techniques used for disease treatment could be repurposed for harm, with AI potentially enabling less experienced individuals to conduct dangerous experiments. While current AI-driven synthetic biology still requires significant manual lab work, its rapid evolution raises concerns about future capabilities. The increasing number of labs engaged in such research globally, irrespective of the scientific specifics, heightens accidental release risks. A hypothetical scenario of an accidental release from a deliberate research program is considered more worrying than a state-sponsored bioweapon attack. Intelligence assessments indicate that countries like China, North Korea, and Russia possess the capability to develop biological weapons. However, AI also offers potential for bolstering biodefense and improving pandemic response capabilities. The U.S. government asserts its readiness to address emerging public health threats, citing past successful responses to outbreaks.